1. #DemandLowerListPrices
- As COVID-19 severely threatens the diabetes community’s health and finances, more than 60 people with diabetes and Patients For Affordable Drugs penned an open letter demanding lower list prices on insulin. — (P4AD)
2. Preparation + Opportunity
- The global pandemic has put a lot of Congressional goals on the backburner this spring. But with millions of Americans facing pay cuts and layoffs, it’s more urgent than ever to address exorbitant drug prices, and Congress still has a great opportunity to act come fall. — (STAT)
3. Put a Cap On It
- Following the lead of several other states, Washington approved a bill that would limit out-of-pocket costs for insulin to $100 for a 30-day supply. While the Big 3 insulin manufacturers should drop the price for all people with diabetes, this is a start. — (The Seattle Times)